Dr Reddy S Laboratories Limited Net Income per Employee (RDY), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Dr Reddy s Laboratories Limited  (NYSE: RDY)
 

Dr Reddy S Laboratories Limited Net Income per Employee

RDY's Quarterly Results, Trends, Rankings, Statistics
Dr Reddy S Laboratories Limited's Income per employee fell in the fourth quarter 2026 on a trailing twelve month basis to $ 20,545, but the productivity of Dr Reddy S Laboratories Limited's 22,000 employees remained above the company average.
The Healthcare sector has seen employees of 67 other companies achieving higher income per employee. While Dr Reddy S Laboratories Limited's total ranking has deteriorated compared to the previous quarter from 0 to 1774.


What is Income per Employee Ratio?






RDY Net Income per Employee (Mar 31 2026)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Mar 31 2025)
IV. Quarter
Y / Y Net Income Change -32.64 % - - - 0.45 %
Net Income per Employee (TTM) $ 20,545 30,500 30,500 30,500 30,500
RDY's Total Ranking # 1774 # 0 # # #
Seq. Net Income Change - - - - -


RDY Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 155
Overall Market # 1774

Net Income per Employee Statistics
High Average Low
$ 30,500 $ 18,020 $ 6,864
(Mar 31 2025)   (Mar 31 2018)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Masimo Corp  34,681.82 $ 76.300  Million 2,200 
Livanova Plc  32,468.18 $ 107.145  Million 3,300 
Haemonetics Corporation  32,189.22 $ 97.308  Million 3,023 
Tenet Healthcare Corp  26,777.78 $ 2,651.000  Million 99,000 
Pediatrix Medical Group Inc   26,578.64 $ 174.223  Million 6,555 
Lifevantage Corp  25,793.72 $ 5.752  Million 223 
Repligen Corp  25,698.50 $ 51.397  Million 2,000 
Nature s Sunshine Products inc   25,663.77 $ 20.685  Million 806 
Nrc Health  25,308.12 $ 9.035  Million 357 
Option Care Health Inc   24,943.87 $ 206.186  Million 8,266 
Hca Healthcare Inc   24,418.75 $ 7,814.000  Million 320,000 
Bio rad Laboratories Inc   22,657.72 $ 168.800  Million 7,450 
Privia Health Group Inc   22,340.95 $ 27.390  Million 1,226 
Revvity Inc  21,789.27 $ 239.682  Million 11,000 
Nephros Inc   21,555.56 $ 0.776  Million 36 
Amneal Pharmaceuticals Inc   21,331.18 $ 181.315  Million 8,500 
Align Technology inc   21,187.38 $ 429.892  Million 20,290 
Dr Reddy s Laboratories Limited  20,545.45 $ 452.000  Million 22,000 
Encompass Health Corporation  19,304.76 $ 810.800  Million 42,000 
Quest Diagnostics Inc  18,859.65 $ 1,075.000  Million 57,000 
Tactile Systems Technology Inc   18,689.69 $ 20.297  Million 1,086 
Merit Medical Systems Inc  18,578.27 $ 139.337  Million 7,500 
Adagio Medical Holdings inc   17,512.20 $ 0.718  Million 41 
Infusystem Holdings Inc  16,725.16 $ 7.911  Million 473 
Henry Schein Inc   16,720.00 $ 418.000  Million 25,000 
Exagen Inc   16,659.09 $ 3.665  Million 220 
Chemed Corporation  16,430.52 $ 259.783  Million 15,811 
Fonar Corporation  16,401.01 $ 8.529  Million 520 
Becton Dickinson And Company  15,805.56 $ 1,138.000  Million 72,000 
The Cooper Companies Inc   15,720.00 $ 235.800  Million 15,000 


Date modified: 2026-07-07T13:23:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.